Back to top

Kymera climbs after expedited timeline for mid-stage eczema trial

Kymera climbs after expedited timeline for mid-stage eczema trial

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Kymera Therapeutics, Inc. (KYMR)